iatroX logo
brainstormaskiatroX
knowledge centreblog
Knowledge Centre / Keratoacanthoma (KA)

Keratoacanthoma (KA)

Overview and management of rapidly growing skin lesion.

Reviewed by Dr Kola Tytler MBBS CertHE MBA MRCGP (General Practitioner)
Last reviewed: 21 October 2025
Dermatology

Clinical Guidelines

Keratoacanthoma - Primary Care Dermatology Society (PCDS) Clinical Guidance
National
PCDS Clinical Guidance: Keratoacanthoma
National
Guidelines of care for the management of cutaneous squamous cell carcinoma
Local
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Basal Cell and Squamous Cell Skin Cancers
Local
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines): Basal Cell and Squamous Cell Skin Cancers
Local
NCCN Clinical Practice Guidelines in Oncology: Basal Cell and Squamous Cell Skin Cancers
Local

Recent iatroX Q&As

  • How should I approach the management of a keratoacanthoma in a patient with a history of skin cancer?Updated: 8/22/2025
  • What are the recommended referral criteria for a keratoacanthoma to a dermatologist?Updated: 8/22/2025
  • What follow-up care is necessary for patients treated for keratoacanthoma to monitor for recurrence?Updated: 8/22/2025
askiatroX
privacytermshow it workscpdinsights
Download on the App StoreGet it on Google Play